Preclinical biotech developing antibody therapies for solid and hematologic tumors.
Industry: Health Care
Latest Trade: $2.08 -1.74 (-45.5%)
First Day Return: -17.5%
Return from IPO: -76.1%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 09/17/2021 |
Offer Price | $16.00 |
Price Range $14.00 - $16.00 | |
Offer Shares (mm) | 10.5 |
Deal Size ($mm) | $168 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 10/07/2021 |
Offer Price | $16.00 |
Price Range $14.00 - $16.00 | |
Offer Shares (mm) | 10.5 |
Deal Size ($mm) | $168 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
BofA Securities |
Jefferies |
more |
Company Data | |
---|---|
Headquarters | Cambridge, MA, United States |
Founded | 2018 |
Employees at IPO | 38 |
Website www.pyxisoncology.com |